The DOI matches its Crossref record; 490 of the 490 references it cites were found in a registry or an index.
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
Abstract
Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the patients treated since then are probably numbered in the millions. Fifty to 90% of hyperthyroid patients are cured within 1 yr after 131I therapy. With longer follow-up, permanent hypothyroidism seems inevitable in Graves' disease, whereas this risk is much lower when treating toxic nodular goiter. The side effect causing most concern is the potential induction of ophthalmopathy in predisposed individuals. The response to 131I therapy is to some extent related to the radiation dose. However, calculation of an exact thyroid dose is error-prone due to imprecise measurement of the 131I biokinetics, and the importance of internal dosimetric factors, such as the thyroid follicle size, is probably underestimated. Besides these obstacles, several potential confounders interfere with the efficacy of 131I therapy, and they may even interact mutually and counteract each other. Numerous studies have evaluated the effect of 131I therapy, but results have been conflicting due to differences in design, sample size, patient selection, and dose calculation. It seems clear that no single factor reliably predicts the outcome from 131I therapy. The individual radiosensitivity, still poorly defined and impossible to quantify, may be a major determinant of the outcome from 131I therapy. Above all, the impact of 131I therapy relies on the iodine-concentrating ability of the thyroid gland. The thyroid 131I uptake (or retention) can be stimulated in several ways, including dietary iodine restriction and use of lithium. In particular, recombinant human thyrotropin has gained interest because this compound significantly amplifies the effect of 131I therapy in patients with nontoxic nodular goiter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Demaria, S., Kawashima, N., Yang, A. M., Devitt, M. L., Babb, J. S., Allison, J. P., & Formenti, S. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.728.11.2 · Cited by 1,022
Systemic effects of local radiotherapy
Formenti, S. C., & Demaria, S. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70082-8 · Cited by 1,021
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
Matsumura, S., Wang, B., Kawashima, N., Braunstein, S., Badura, M., Cameron, T. O., Babb, J. S., Schneider, R. J., Formenti, S. C., Dustin, M. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3099 · Cited by 711
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
Schlumberger, M., Catargi, B., Borget, I., Deandreis, D., Zerdoud, S., Bridji, B., Bardet, S., Leenhardt, L., Bastie, D., Schvartz, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108586 · Cited by 684
AACE/AME/ETA Task Force on Thyroid Nodules, Gharib, H., Papini, E., Paschke, R., Duick, D. S., Valcavi, R., Hegedüs, L., & Vitti, P. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346587 · Cited by 552
Self-citationOccurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Epidemiology and Prevention of Graves' Ophthalmopathy
Wiersinga, W. M., & Bartalena, L. (2002) · Thyroid · doi:10.1089/105072502761016476 · Cited by 458
Pacini, F., Ladenson, P. W., Schlumberger, M., Driedger, A., Luster, M., Kloos, R. T., Sherman, S., Haugen, B., Corone, C., Molinaro, E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1651 · Cited by 450
Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428
Thyrotoxicosis and Thyroid Storm
Nayak, B., & Burman, K. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.008 · Cited by 394
Cancer Mortality Following Treatment for Adult Hyperthyroidism
Ron, E. (1998) · JAMA · doi:10.1001/jama.280.4.347 · Cited by 377
Radioactive Iodine and the Salivary Glands
Mandel, S. J., & Mandel, L. (2003) · Thyroid · doi:10.1089/105072503321582060 · Cited by 375
WARTOFSKY, L., GLINOER, D., SOLOMON, B., NAGATAKI, S., LAGASSE, R., NAGAYAMA, Y., & IZUMI, M. (1991) · Thyroid · doi:10.1089/thy.1991.1.129 · Cited by 374
Iuchi, T., Akaike, M., Mitsui, T., Ohshima, Y., Shintani, Y., Azuma, H., & Matsumoto, T. (2003) · Circulation Research · doi:10.1161/01.res.0000050588.35034.3c · Cited by 357
Bartalena, L., & Tanda, M. L. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0806317 · Cited by 336
Hänscheid, H., Laßmann, M., Luster, M., Thomas, S. R., Pacini, F., Ceccarelli, C., Ladenson, P. W., Wahl, R. L., Schlumberger, M. J., Ricard, M., et al. (2006) · PubMed · Cited by 329
Iyer, N. G., Morris, L. G. T., Tuttle, R. M., Shaha, A. R., & Ganly, I. (2011) · Cancer · doi:10.1002/cncr.26070 · Cited by 321
Torring, O. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2986 · Cited by 311
Smoking and thyroid disorders--a meta-analysis
Vestergaard, P. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460153 · Cited by 311
Mortality after the Treatment of Hyperthyroidism with Radioactive Iodine
Franklyn, J. A., Maisonneuve, P., Sheppard, M. C., Betteridge, J., & Boyle, P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381103 · Cited by 309
Grozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A., & Leibovici, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0448 · Cited by 296
Cigarette Smoking and Treatment Outcomes in Graves Ophthalmopathy
Bartalena, L., Marcocci, C., Tanda, M. L., Manetti, L., Dell'Unto, E., Bartolomei, M. P., Nardi, M., Martino, E., & Pinchera, A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00010 · Cited by 295
Kogai, T. (1997) · Endocrinology · doi:10.1210/en.138.6.2227 · Cited by 286
Age and Gender Predict the Outcome of Treatment for Graves' Hyperthyroidism
Allahabadia, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1038 · Cited by 286
Radioiodine Therapy for Hyperthyroidism
Ross, D. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1007101 · Cited by 284
Sawka, A. M., Brierley, J. D., Tsang, R. W., Thabane, L., Rotstein, L., Gafni, A., Straus, S., & Goldstein, D. P. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.02.007 · Cited by 273
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism
Filetti, S., Bidart, J., Arturi, F., Caillou, B., Russo, D., & Schlumberger, M. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410443 · Cited by 269
Radioiodine Treatment of Hyperthyroidism--Prognostic Factors for Outcome
Allahabadia, A. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3611 · Cited by 264
HERTZ, S. (1946) · Journal of the American Medical Association · doi:10.1001/jama.1946.02870190005002 · Cited by 263
Träisk, F., Tallstedt, L., Abraham-Nordling, M., Andersson, T., Berg, G., Calissendorff, J., Hallengren, B., Hedner, P., Lantz, M., Nyström, E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0747 · Cited by 262
Thyrotropin receptor-associated diseases: from adenomata to Graves disease
Davies, T. F. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26031 · Cited by 262
High Dose 131I Therapy for the Treatment of Hyperthyroidism Caused by Graves' Disease
Alexander, E. K. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1073 · Cited by 251
Lassmann, M., Hänscheid, H., Chiesa, C., Hindorf, C., Flux, G., & Luster, M. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0761-x · Cited by 251
Franklyn, J. A., Maisonneuve, P., Sheppard, M., Betteridge, J., & Boyle, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12295-x · Cited by 243
Daw Mukhtar, E., Ann Pyle, G., Rees Smith, B., Hall, R., & Vice, P. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91629-3 · Cited by 236
Torun, A. N., Kulaksizoglu, S., Kulaksizoglu, M., Pamuk, B. O., Isbilen, E., & Tutuncu, N. B. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03348.x · Cited by 234
Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.
Solans, R., Bosch, J., Galofré, P., et al. (2001) · PubMed · Cited by 232
Lazarus, J. H. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.002 · Cited by 230
Quality of life in patients with benign thyroid disorders. A review
Watt, T., Groenvold, M., Rasmussen, A. K., Bonnema, S. J., Hegedüs, L., Bjorner, J. B., & Feldt-Rasmussen, U. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02124 · Cited by 228
Self-citationKöhrle, J., & Gärtner, R. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.08.002 · Cited by 221
Lytton, S. D., Ponto, K. A., Kanitz, M., Matheis, N., Kohn, L. D., & Kahaly, G. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2470 · Cited by 219
Putting Propylthiouracil in Perspective
Cooper, D. S., & Rivkees, S. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0850 · Cited by 212
Ohta, K., Endo, T., Haraguchi, K., Hershman, J. M., & Onaya, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7493 · Cited by 211
Long‐term follow‐up study of radioiodine treatment of hyperthyroidism
Metso, S., Jaatinen, P., Huhtala, H., Luukkaala, T., Oksala, H., & Salmi, J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02152.x · Cited by 205
A Randomized Comparison of Radioiodine Doses in Graves’ Hyperthyroidism
Leslie, W. D., Ward, L., Salamon, E. A., Ludwig, S., Rowe, R. C., & Cowden, E. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020805 · Cited by 204
Read, C. H., Tansey, M. J., & Menda, Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031223 · Cited by 204
An Immunohistochemical Study of Na+/I- Symporter in Human Thyroid Tissues and Salivary Gland Tissues
Jhiang, S. M. (1998) · Endocrinology · doi:10.1210/en.139.10.4416 · Cited by 203
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer
Kogai, T., Taki, K., & Brent, G. A. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01143 · Cited by 203
Walter, M. A., Briel, M., Christ-Crain, M., Bonnema, S. J., Connell, J., Cooper, D. S., Bucher, H. C., Müller-Brand, J., & Müller, B. (2007) · BMJ · doi:10.1136/bmj.39114.670150.be · Cited by 202
Self-citationDriessens, N., Versteyhe, S., Ghaddhab, C., Burniat, A., De Deken, X., Van Sande, J., Dumont, J.-E., Miot, F., & Corvilain, B. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-09-0020 · Cited by 201
Acharya, S. H., Avenell, A., Philip, S., Burr, J., Bevan, J. S., & Abraham, P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03279.x · Cited by 200
Schroeder, P. R., Haugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Sherman, S. I., Cooper, D. S., Schuff, K. G., Braverman, L. E., Skarulis, M. C., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2064 · Cited by 198
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
Van Nostrand, D. (2009) · Thyroid · doi:10.1089/thy.2009.1611 · Cited by 195
Schlumberger, M. J., de Vathaire, F., Ceccarelli, C., Delisle, M. J., Francese, C., Couette, J. E., Pinchera, A., & Parmentier, C. (1996) · PubMed · Cited by 193
Radioactive Iodine as an Indicator in the Study of Thyroid Physiology.
HERTZ, S., Roberts, A., & Evans, R. D. (1938) · Experimental Biology and Medicine · doi:10.3181/00379727-38-9915p · Cited by 191
Schmutzler, C., Winzer, R., Meissner-Weigl, J., & Köhrle, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7715 · Cited by 191
Long-Term Follow-up Study of Compensated Low-Dose131I Therapy for Graves' Disease
Sridama, V., McCormick, M., Kaplan, E. L., Fauchet, R., & DeGroot, L. J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408163110702 · Cited by 190
Simon, D., Körber, C., Krausch, M., Segering, J., Groth, P., Görges, R., Grünwald, F., Müller-Gärtner, H., Schmutzler, C., Köhrle, J., et al. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-001-0737-6 · Cited by 186
Thyroid Function and Mortality in Patients Treated for Hyperthyroidism
Franklyn, J. A. (2005) · JAMA · doi:10.1001/jama.294.1.71 · Cited by 186
Thyroid nodule guidelines: agreement, disagreement and need for future research
Paschke, R., Hegedüs, L., Alexander, E., Valcavi, R., Papini, E., & Gharib, H. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.1 · Cited by 184
Self-citationSacks, W., Fung, C. H., Chang, J. T., Waxman, A., & Braunstein, G. D. (2010) · Thyroid · doi:10.1089/thy.2009.0455 · Cited by 182
Sawka, A. M., Lakra, D. C., Lea, J., Alshehri, B., Tsang, R. W., Brierley, J. D., Straus, S., Thabane, L., Gafni, A., Ezzat, S., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03222.x · Cited by 181
(2005) · PubMed · Cited by 180
Luster, M., Lippi, F., Jarzab, B., Perros, P., Lassmann, M., Reiners, C., & Pacini, F. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00830 · Cited by 180
Radiation chemistry comes before radiation biology
O'Neill, P., & Wardman, P. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000802640401 · Cited by 178
Large, Compressive Goiters Treated with Radioiodine
Huysmans, D. A. K. C., Hermus, A. R. M. M., Corstens, F. H. M., Barentsz, J. O., & Kloppenborg, P. W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-10-199411150-00005 · Cited by 174
Radioiodine treatment of multinodular non-toxic goitre.
Nygaard, B., Hegedüs, L., Gervil, M., Hjalgrim, H., Søe-Jensen, P., & Hansen, J. M. (1993) · BMJ · doi:10.1136/bmj.307.6908.828 · Cited by 173
Self-citationSTUDIES IN IODINE METABOLISM BY THE USE OF A NEW RADIOACTIVE ISOTOPE OF IODINE
Hamilton, J. G., & Soley, M. H. (1939) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1939.127.3.557 · Cited by 172
A critical review and meta-analysis of the association between overt hyperthyroidism and mortality
Brandt, F., Green, A., Hegedüs, L., & Brix, T. H. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0299 · Cited by 170
Self-citationWesche, M. F. T. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.998 · Cited by 168
Watanabe, N., Narimatsu, H., Noh, J. Y., Yamaguchi, T., Kobayashi, K., Kami, M., Kunii, Y., Mukasa, K., Ito, K., & Ito, K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2221 · Cited by 167
Antithyroid effects of lithium
Berens, S. C., Bernstein, R. S., Robbins, J., & Wolff, J. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106352 · Cited by 167
An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine
Rivkees, S. A., & Dinauer, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1239 · Cited by 164
Radioiodine-induced thyroid storm
McDermott, M. T., Kidd, G. S., Dodson, L. E., & Hofeldt, F. D. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91217-2 · Cited by 163
Cigarette Smoking and the Thyroid
BERTELSEN, J. B., & HEGEDÜS, L. (1994) · Thyroid · doi:10.1089/thy.1994.4.327 · Cited by 161
Self-citationBonnema, S. J., Bertelsen, H., Mortensen, J., Andersen, P. B., Knudsen, D. U., Bastholt, L., & Hegedüs, L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6052 · Cited by 157
Self-citationFuruya, F., Shimura, H., Suzuki, H., Taki, K., Ohta, K., Haraguchi, K., Onaya, T., Endo, T., & Kobayashi, T. (2004) · Endocrinology · doi:10.1210/en.2003-1258 · Cited by 157
Lithium as a Potential Adjuvant to 131I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma
Koong, S.-S., Reynolds, J. C., Movius, E. G., Keenan, A. M., Ain, K. B., Lakshmanan, M. C., & ROBBINS, J. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5527 · Cited by 155
Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
Jarløv, A. E., Hegedüst, L., Kristensen, L. Ø., Nygaard, B., & Hansen, J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02039.x · Cited by 155
Testicular dose and fertility in men following I131 therapy for thyroid cancer
Hyer, S. L., Vini, L., O'Connell, M. E. A., Pratt, B. E., & Harmer, C. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.t01-1-01545.x · Cited by 152
Radioiodine and the Treatment of Hyperthyroidism: The Early History *
Sawin, C. T., & Becker, D. V. (1997) · Thyroid · doi:10.1089/thy.1997.7.163 · Cited by 151
THE TREATMENT OF HYPERTHYROIDISM WITH RADIOACTIVE IODINE
Chapman, E. M., & EVANS, R. D. (1946) · JAMA · doi:10.1001/jama.1946.02870190010003 · Cited by 150
Pluijmen, M. J. H. M., Eustatia‐Rutten, C. F. A., Goslings, B. M., Stokkel, M. P. M., Pereira, A. M., Diamant, M., Romijn, J. A., & Smit, J. W. A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01735.x · Cited by 150
Nygaard, B., Hegedüs, L., Gerhard Nielsen, K., Ulriksen, P., & Hansen, J. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00635.x · Cited by 148
Self-citationCigarette Smoking and Risk of Clinically Overt Thyroid Disease
Brix, T. H., Hansen, P. S., Kyvik, K. O., & Hegedűs, L. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.661 · Cited by 148
Self-citationIncreased Cardiovascular and Cancer Mortality after Radioiodine Treatment for Hyperthyroidism
Metso, S., Jaatinen, P., Huhtala, H., Auvinen, A. P., Oksala, H., & Salmi, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2321 · Cited by 148
Imseis, R. E., VanMiddlesworth, L., MASSIE, J. D., Bush, A. J., & Vanmiddlesworth, N. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4538 · Cited by 147
Increased cancer incidence after radioiodine treatment for hyperthyroidism
Metso, S., Auvinen, A. P., Huhtala, H., Salmi, J., Oksala, H., & Jaatinen, P. (2007) · Cancer · doi:10.1002/cncr.22635 · Cited by 146
Chiovato, L., Fiore, E., Vitti, P., Rocchi, R., Rago, T., Dokić, D., Latrofa, F., Mammoli, C., Lippi, F., Ceccarelli, C., et al. (1998) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.83.1.4492 · Cited by 146
Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
Grewal, R. K., Larson, S. M., Pentlow, C. E., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.061382 · Cited by 144
Andrade, V. A., Gross, J. L., & Maia, A. L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7707 · Cited by 143
Tuttle, R. M., Brokhin, M., Omry, G., Martorella, A. J., Larson, S. M., Grewal, R. K., Fleisher, M., & Robbins, R. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049072 · Cited by 141
Lee, J., Yun, M. J., Nam, K., Chung, W. Y., Soh, E.-Y., & Park, C. S. (2010) · Thyroid · doi:10.1089/thy.2009.0187 · Cited by 140
Remission of Graves’ disease during anti-thyroid drug therapy. Time to reconsider the mechanism?
Laurberg, P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02295 · Cited by 139
Kung, A. W. C., Yau, C., & Cheng, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.7913934 · Cited by 139
EVIDENCE FOR AN EFFECT OF ANTITHYROID DRUGS ON THE NATURAL HISTORY OF GRAVES' DISEASE
Weetman, A. P., McGregor, A. M., & Hall, R. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb03456.x · Cited by 139
Szkudlinski, M. W., THOTAKURA, N. R., Bucci, I., Joshi, L., Tsai, A. M., East-Palmer, J., Shiloach, J., & Weintraub, B. D. (1993) · Endocrinology · doi:10.1210/endo.133.4.8404588 · Cited by 138
Management of the Nontoxic Multinodular Goiter: A North American Survey
Bonnema, S. J., Bennedbæk, F. N., Ladenson, P. W., & Hegedűs, L. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8169 · Cited by 138
Self-citationÇağlar, M., Tuncel, M., & Alpar, R. (2002) · Clinical Nuclear Medicine · doi:10.1097/00003072-200211000-00003 · Cited by 138
Laßmann, M., Hänscheid, H., Gassen, D., Biko, J., Meineke, V., Reiners, C., & Scherthan, H. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.071357 · Cited by 136
THOTAKURA, N. R., Desai, R. K., Bates, L., Cole, E. S., Pratt, B. M., & Weintraub, B. D. (1991) · Endocrinology · doi:10.1210/endo-128-1-341 · Cited by 135
Hou, P., Bojdani, E., & Xing, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1888 · Cited by 130
Male reproductive function in relation with thyroid alterations
Krassas, G. E., & Pontikides, N. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.03.003 · Cited by 130
Garsi, J., Schlumberger, M. J., Rubino, C., Ricard, M., Labbé, M., Ceccarelli, C., Schvartz, C., Henry-Amar, M., Bardet, S., & de Vathaire, F. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046599 · Cited by 127
Lithium treatment and thyroid abnormalities.
Bocchetta, A., & Loviselli, A. (2006) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-2-23 · Cited by 127
Success Rate of Radioiodine Therapy in Graves' Disease: The Influence of Thyrostatic Medication
Sabri, O., Zimny, M., Schulz, G., Schreckenberger, M., Reinartz, P., Willmes, K., & Buell, U. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5588 · Cited by 126
CLINICAL SIGNIFICANCE OF PROBENECID TEST
Lakke, J. P. W. F., Korf, J., van Praag, H. M., Minderhoud, J. M., & Schut, T. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90770-8 · Cited by 126
Suppression of Thyroid Radioiodine Uptake by Various Doses of Stable Iodide
Sternthal, E., Lipworth, L., Stanley, B. A., Abreau, C. M., Fang, S.-L., & Braverman, L. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011063031903 · Cited by 125
The Use of Lithium in the Treatment of Thyrotoxicosis
Temple, R., Berman, M. D., Robbins, J., & Wolff, J. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107094 · Cited by 125
131 I Effective Half-Life and Dosimetry in Thyroid Cancer Patients
Remy, H., Borget, I., Leboulleux, S., Guilabert, N., Lavielle, F., Garsi, J., Bournaud, C., Gupta, S., Schlumberger, M. J., & Ricard, M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.052464 · Cited by 125
Retinoic acid for redifferentiation of thyroid cancer--does it hold its promise?
Grüning, T., Tiepolt, C., Zöphel, K., Bredow, J., Kropp, J., & Franke, W. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480395 · Cited by 125
Cancer mortality after iodine‐131 therapy for hyperthyroidism
Hall, P., Berg, G., Bjelkengren, G., Boice, J. D., Ericsson, U., Hallquist, A., Lidberg, M., Lundell, G., Tennvall, J., Wiklund, K., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500611 · Cited by 124
Redifferentiation therapy-induced radioiodine uptake in thyroid cancer.
Grünwald, F., Menzel, C., Bender, H., PALMEDO, H., Otte, R., Fimmers, R., Risse, J. H., & Biersack, H. J. (1998) · PubMed · Cited by 124
Oxidative Stress in the Thyroid Gland: From Harmlessness to Hazard Depending on the Iodine Content
Poncin, S., Gérard, A.-C., Boucquey, M., Sènou, M., Calderón, P. B., Knoops, B., Lengelé, B., Many, M., & Colin, I. M. (2007) · Endocrinology · doi:10.1210/en.2007-0951 · Cited by 124
Treatment of Graves' Hyperthyroidism with Radioiodine: Results of a Prospective Randomized Study
PETERS, H., FISCHER, C., BOGNER, U., REINERS, C., & SCHLEUSENER, H. (1997) · Thyroid · doi:10.1089/thy.1997.7.247 · Cited by 121
Huysmans, D. A., Nieuwlaat, W., Erdtsieck, R. J., SCHELLEKENS, A. P. M., Bus, J. W., Bravenboer, B., & Hermus, A. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6869 · Cited by 121
Luster, M., Felbinger, R., Dietlein, M., & Reiners, C. (2005) · Thyroid · doi:10.1089/thy.2005.15.1147 · Cited by 120
Radioiodine Therapy for Multinodular Toxic Goiter
Nygaard, B., Hegedüs, L., Ulriksen, P., Nielsen, K. G., & Hansen, J. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.12.1364 · Cited by 120
Self-citationImpact of 131I diagnostic activities on the biokinetics of thyroid remnants.
Laßmann, M., Luster, M., Hänscheid, H., & Reiners, C. (2004) · PubMed · Cited by 119
Nieuwlaat, W., Huysmans, D. A., van den Bosch, H. C. M., Sweep, F. C. G. J., Ross, H., Corstens, F. H. M., & Hermus, A. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021554 · Cited by 119
Kebebew, E., Peng, M., Reiff, E. S., et al. (2006) · Surgery · doi:10.1016/j.surg.2006.07.038 · Cited by 116
Torres, M., Ramirez, L., Simkin, P. H., Braverman, L. E., & Emerson, C. H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7405 · Cited by 115
Management of the nontoxic multinodular goitre: A European questionnaire study
Bonnema, S. J., Bennedbæk, F. N., Wiersinga, W. M., & Hegedűs, L. D. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01060.x · Cited by 115
Self-citationAssociation between lithium use and thyrotoxicosis caused by silent thyroiditis
Miller, K. K., & Daniels, G. H. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01381.x · Cited by 114
Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre.
Hegedűs, L. D., Hansen, B. M., Knudsen, N., & Hansen, J. M. (1988) · BMJ · doi:10.1136/bmj.297.6649.661 · Cited by 114
Self-citationOxidative Stress and Anti-Oxidant Metabolites in Patients with Hyperthyroidism: Effect of Treatement
Bianchi, G., Solaroli, E., Zaccheroni, V., Grossi, G., Bargossi, A., Melchionda, N., & Marchesini, G. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978808 · Cited by 114
Nygaard, B., Knudsen, J. H., Hegedűs, L. D., Veje, A., & Hansen, J. E. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4227 · Cited by 114
Self-citationResults from a Prospective, Randomized Study
Adlerberth, A., Stenström, G., & Hasselgren, P.-O. (1987) · Annals of Surgery · doi:10.1097/00000658-198702000-00013 · Cited by 113
Haugen, B. R., Larson, L. L., Pugazhenthi, U., Hays, W. R., Klopper, J. P., Kramer, C. A., & Sharma, V. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030770 · Cited by 113
Glinoer, D., Nayer, P. D., & Bex, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440475 · Cited by 113
Lippi, F., Capezzone, M., Angelini, F., Taddei, D., Molinaro, E., Pinchera, A., & Pacini, F. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440005 · Cited by 113
Watt, T., Bjorner, J. B., Groenvold, M., Rasmussen, Å. K., Bonnema, S. J., Hegedüs, L., & Feldt-Rasmussen, U. (2009) · Quality of Life Research · doi:10.1007/s11136-009-9460-8 · Cited by 112
Self-citationFestuccia, W. T., Öztezcan, S., Laplante, M., Berthiaume, M., Michel, C., Dohgu, S., Denis, R., Brito, M. N., Brito, N. A., Miller, D. S., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1553 · Cited by 111
Emiliano, A. B., Governale, L. A., Parks, M. A., & Cooper, D. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2752 · Cited by 111
Ceccarelli, C., Bencivelli, W., Vitti, P., Grasso, L., & Pinchera, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02218.x · Cited by 109
Herle, A. J. V., AGATEP, M. L., Padua, D., Totanes, T. L., Canlapan, D., Herle, H. M. L. V., & Juillard, G. J. F. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-755 · Cited by 109
Relationship between cigarette smoking and Graves’ ophthalmopathy
Hegedűs, L. D., Brix, T. H., & Vestergaard, P. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03345276 · Cited by 108
Self-citationThyroid Nodules in Graves' Disease: Classification, Characterization, and Response to Treatment
Carnell, N. E., & VALENTE, W. A. (1998) · Thyroid · doi:10.1089/thy.1998.8.571 · Cited by 108
Silva, M. N. C., Rubio, I. G. S., Romão, R., Gebrin, E. M. M. S., Buchpiguel, C. A., Tomimori, E. K., Camargo, R. Y. A., Cardia, M., & Medeiros-Neto, G. A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01918.x · Cited by 107
Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I
Hilditch, T., Dempsey, M. F., Bolster, A. A., McMenemin, R. M., & Reed, N. S. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0785-6 · Cited by 107
Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages.
Maridonneau‐Parini, I., Errasfa, M., & Russo-Marie, F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114101 · Cited by 106
Cole, E. S., Lee, K. S., Lauziere, K., Kelton, C., Chappel, S. C., Weintraub, B. D., Ferrara, D. T., Peterson, P., Bernasconi, R., Edmunds, T., et al. (1993) · Nature Biotechnology · doi:10.1038/nbt0993-1014 · Cited by 106
Aiello, A., Pandini, G., Frasca, F., Conte, E., Murabito, A., Sacco, A., Genua, M., Vigneri, R., & Belfiore, A. (2006) · Endocrinology · doi:10.1210/en.2005-1610 · Cited by 106
Comparison of Radioiodine with Radioiodine plus Lithium in the Treatment of Graves' Hyperthyroidism
Bogazzi, F., Bartalena, L., Brogioni, S., Scarcello, G., Burelli, A., Campomori, A., Manetti, L., Rossi, G., Pinchera, A., & Martino, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5446 · Cited by 105
Tuttle, R. M., Patience, T. H., & BUDD, S. (1995) · Thyroid · doi:10.1089/thy.1995.5.243 · Cited by 104
Ceccarelli, C., Bencivelli, W., Morciano, D., Pinchera, A., & Pacini, F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7719 · Cited by 103
Ultrasonographic screening for detection of thyroid cancer in patients with Graves’ disease
Kim, W. B., Han, S., Kim, T. Y., Nam‐Goong, I. S., Gong, G., Lee, H. K., Hong, S. J., & Shong, Y. K. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02043.x · Cited by 103
de Rooij, A., Vandenbroucke, J. P., Smit, J. W. A., Stokkel, M. P. M., & Dekkers, O. M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0286 · Cited by 102
TREATMENT OF THYROTOXICOSIS WITH LITHIUM CARBONATE
Lazarus, J. H., Addison, G. M., Richards, A. R., & Owen, G. M. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90808-3 · Cited by 102
Tala, H., Robbins, R. J., Fagin, J. A., Larson, S. M., & Tuttle, R. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0305 · Cited by 102
Invariant Natural Killer T Cells Regulate Breast Cancer Response to Radiation and CTLA-4 Blockade
Pilones, K. A., Kawashima, N., Yang, A. M., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1277 · Cited by 102
Variations in urinary iodine excretion and thyroid function. A 1-year study in healthy men
Andersen, S., Pedersen, K., Pedersen, I. B., & Laurberg, P. T. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440461 · Cited by 101
Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism.
Holm, L., Lundell, G. E. F., Israelsson, A., & Dahlqvist, I. (1982) · PubMed · Cited by 100
Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg, G. E., Michanek, A., Holmberg, E. C., et al. (1996) · PubMed · Cited by 100
Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence
Barclay, M. L., Brownlie, B. E. W., Turner, J. G., & Wells, J. E. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02509.x · Cited by 99
Murakami, Y., Takamatsu, J., Sakane, S., Kuma, K., & Ohsawa, N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784079 · Cited by 99
Comparison of methods for thyroid volume estimation in patients with Graves' disease
van Isselt, J. W., de Klerk, J. M. H., van Rijk, P. P., Gils, A. P. G., Polman, L. J., Kamphuis, C., Meijer, R., & Beekman, F. J. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1101-1 · Cited by 98
Effraimidis, G., Tijssen, J. G. P., & Wiersinga, W. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1548 · Cited by 98
Association of Tobacco Smoking With Goiter in a Low-Iodine-Intake Area
Knudsen, N. J., Bülow, I., Laurberg, P., Ovesen, L., Perrild, H., & Jørgensen, T. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.4.439 · Cited by 97
Nieuwlaat, W., Hermus, A. R., Sivro, F., Corstens, F. H. M., & Huysmans, D. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8014 · Cited by 97
Braga, M., Walpert, N., Burch, H. B., Solomon, B. L., & Cooper, D. S. (2002) · Thyroid · doi:10.1089/105072502753522365 · Cited by 96
Nielsen, V. E., Bonnema, S. J., Boel-Jørgensen, H., Grupe, P., & Hegedűs, L. D. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.14.1476 · Cited by 95
Self-citationKolbert, K. S., Pentlow, K. S., Pearson, J. R., Sheikh, A., Finn, R. D., Humm, J. L., & Larson, S. M. (2007) · PubMed · Cited by 94
Radioiodine treatment for benign thyroid diseases
Weetman, A. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02841.x · Cited by 93
Management of Graves' ophthalmopathy
Wiersinga, W. M. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0497 · Cited by 93
Tuttle, R. M., Fleisher, M., Francis, G. L., & Robbins, R. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8388 · Cited by 93
Graves’ Orbitopathy Activation after Radioactive Iodine Therapy with and without Steroid Prophylaxis
Vannucchi, G., Campi, I., Covelli, D., Dazzi, D., Currò, N., Simonetta, S., Ratiglia, R., Beck-Peccoz, P., & Salvi, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0506 · Cited by 92
The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease
Hancock, L. D., Tuttle, R. M., LeMar, H. J., Bauman, J. W., & Patience, T. H. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2741075.x · Cited by 92
Abalovich, M., Llesuy, S., Gutierrez, S., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01850.x · Cited by 92
Elisei, R., Schlumberger, M. J., Driedger, A. A., Reiners, C., Kloos, R. T., Sherman, S. I., Haugen, B. R., Corone, C., Molinaro, E., Grasso, L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0869 · Cited by 92
Fortunati, N., Catalano, M. G., Arena, K., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031407 · Cited by 92
Optimized dose planning of radioiodine therapy of benign thyroidal diseases.
Bockisch, A., Jamitzky, T., Derwanz, R., & Biersack, H. J. (1993) · PubMed · Cited by 92
Lithium as a Potential Adjuvant to 131I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma
Koong, S.-S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.3.912 · Cited by 92
Deoxyribonucleic Acid Damage and Spontaneous Mutagenesis in the Thyroid Gland of Rats and Mice
Maier, J., STEEG, H. V., van Oostrom, C., Karger, S., Paschke, R., & Krohn, K. (2006) · Endocrinology · doi:10.1210/en.2005-1669 · Cited by 91
Reinhardt, M. J., Brink, I., Joe, A., von Mallek, D., Ezziddin, S., PALMEDO, H., & Krause, T. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0877-3 · Cited by 91
Molecular cloning of the human thyrotropin‐β subunit gene
Hayashizaki, Y., Miyai, K., Kato, K., & Matsubara, K. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80409-9 · Cited by 91
Ross, D. S., Ridgway, E. C., & DANIELS, G. H. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-488 · Cited by 90
Hansen, P. S., Brix, T. H., Bennedbæk, F. N., Bonnema, S. J., Kyvik, K. O., & Hegedűs, L. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031999 · Cited by 90
Self-citationBonnema, S. J., Nielsen, V. E., Boel-Jørgensen, H., Grupe, P., Andersen, P. B., Bastholt, L., & Hegedűs, L. D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0501 · Cited by 90
Self-citationBonnema, S. J., Bennedbæk, F. N., Veje, A., Marving, J., & Hegedűs, L. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0247 · Cited by 90
Self-citationMarcocci, C., Gianchecchi, D., Masini, I., Golia, F., Ceccarelli, C., Bracci, E., Fenzi, G., & Pinchera, A. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03348615 · Cited by 89
Sudden Enlargement of Local Recurrent Thyroid Tumor after Recombinant Human TSH Administration
Braga, M., Ringel, M. D., & Cooper, D. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8055 · Cited by 89
Catargi, B., Leprat, F., Guyot, M., Valli, N., Ducassou, D., & Tabarin, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410117 · Cited by 89
Sawka, A. M., Ibrahim-zada, I., Galacgac, P., Tsang, R. W. C., Brierley, J. D., Ezzat, S., & Goldstein, D. P. (2010) · Thyroid · doi:10.1089/thy.2010.0055 · Cited by 89
Bogazzi, F., Giovannetti, C., Fessehatsion, R., Tanda, M. L., Campomori, A., Compri, E., Rossi, G., Ceccarelli, C., Vitti, P., Pinchera, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1655 · Cited by 88
The Effects of Recombinant TSH on Bone Turnover Markers and Serum Osteoprotegerin and RANKL Levels
Martini, G., Gennari, L., Paola, V. D., Pilli, T., Salvadori, S., Merlotti, D., Valleggi, F., Campagna, M. S., Franci, B., Avanzati, A., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0166 · Cited by 87
Bal, C., Kumar, A., & Pandey, R. M. (2002) · Thyroid · doi:10.1089/105072502760043486 · Cited by 87
Determinants of longterm outcome of radioiodine therapy of sporadic non‐toxic goitre
Moli, R. L., Wesche, M. F. T., Buul, M. M. C. T.-V., & Wiersinga, W. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00734.x · Cited by 87
Perrild, H., Hegedűs, L. D., Baastrup, P. C., Kayser, L., & Kastberg, S. E. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.11.1518 · Cited by 87
Self-citationHolst, J. P., Burman, K. D., Atkins, F., Umans, J. G., & Jonklaas, J. (2005) · Thyroid · doi:10.1089/thy.2005.15.1321 · Cited by 86
Radioiodine therapy of thyroid autonomy
Reiners, C., & Schneider, P. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0910-6 · Cited by 85
Turska, M., Jarząb, B., Handkiewicz-Junak, D., Roskosz, J., Puch, Z., Wygoda, Z., Kukulska, A., Jurecka‐Lubieniecka, B., Hasse-Lazar, K., & Zajusz, A. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1190-5 · Cited by 85
Burch, H. B., Solomon, B. L., Cooper, D. S., Ferguson, P., Walpert, N., & Howard, R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7639 · Cited by 85
Transition of Nodular Toxic Goiter to Autoimmune Hyperthyroidism Triggered by 131I Therapy
NYGAARD, B., FABER, J., VEJE, A., HEGEDÜS, L., & HANSEN, J. M. (1999) · Thyroid · doi:10.1089/thy.1999.9.477 · Cited by 84
Self-citationEvaluation of oxidative status in patients with hyperthyroidism
Aslan, M., Cosar, N., Çelık, H., Aksoy, N., Dülger, A. C., Beğenik, H., Soyoral, Y. U., Küçükoğlu, M. E., & Selek, Ş. (2011) · Endocrine · doi:10.1007/s12020-011-9472-3 · Cited by 84
Menzel, C., Kranert, W. T., Döbert, N., Diehl, M., Fietz, T. J., Hamscho, N., Berner, U., & Grünwald, F. (2003) · PubMed · Cited by 83
Cited by
Smith, T. J., & Hegedüs, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,257
Self-citation2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K., & Pearce, S. H. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 940
Self-citationDe Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Self-citationClinical Utility of TSH Receptor Antibodies
Barbesino, G., & Tomer, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4309 · Cited by 237
Metadata
- Authors
- Bonnema, S. J., & Hegedüs, L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2012-09-07
- Volume
- 33
- Issue
- 6
- Pages
- 920-980
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2126241583
- Cited by
- 339
- References
- 490
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.